Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (3,004,619) $ (1,259,590)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 2,946 346
Amortization expense 16,205 10,954
Stock issued for services 249,100
Accretion of debt discount 368,205 275,333
Accretion of original issuance costs 61,283 67,823
Interest expense converted to notes payable 30,800
Impairment of assets 536,047
Changes in operating assets and liabilities:    
Other current assets (2,075)
Other assets (20,711)
Accounts payable 23,669 15,095
Accrued payroll and payroll taxes (58,635) 59,707
Other current liabilities 23,603 523
Net cash used in operating activities (1,774,182) (829,809)
Cash flows from investing activities:    
Purchase of property and equipment (29,264)
Website development costs (10,799)
Net cash used in investing activities (29,264) (10,799)
Cash flows from financing activities:    
Proceeds from short-term convertible notes 250,000 925,010
Repayment of short-term convertible notes (55,000)
Common stock and warrants issued for cash 1,865,000
Net cash provided by financing activities 2,060,000 925,010
Net increase in cash 256,554 84,402
Cash at beginning of period 84,402
Cash at end of period 340,956 84,402
Cash paid during the period for:    
Interest
Income taxes
Non-cash investing and financing activities:    
Beneficial conversion feature in conjunction with debt issuance 101,972 129,938
Warrants issued to third parties in conjunction with debt issuance 188,069 223,560
Original issue discount issued in conjunction with debt 126,030 85,495
Common stock issued to third parties in conjunction with conversion of debt 236,715 396,000
Issuance of common stock in conjunction with cashless exercise of warrants $ 6